Orphan Drug Status

Continuing coverage of orphan drug status and what it means for the sector, patients and investors.

1. 

   Aug 16 · 10:08Market Watch

   Why Orphan Drug Status Has Become One of Biotech's Most Powerful Market Catalysts

2. 

   Aug 15 · 16:18Market Watch

   Why Orphan Drug Status Has Become One of Biotech's Most Powerful Market Signals

3. 

   Aug 13 · 22:46Market Watch

   Why Orphan Drug Status Has Become One of Biotech's Most Powerful Market Signals

4. 

   Aug 5 · 13:18Market Watch

   The Quiet Catalyst Sending Biotech Stocks Soaring Overnight

5. 

   Aug 4 · 11:43Market Watch

   Orphan Drug Status Is One of the Most Powerful Market Signals Biotech Investors Often Overlook

6. 

   Aug 3 · 13:15Market Watch

   The Quiet Catalyst Behind Biotech's Biggest Stock Surges This Year

7. 

   Aug 2 · 22:09Market Watch

   Orphan Drug Status Is Quietly Reshaping the Biotech Stock Market

8. 

   Aug 1 · 14:32Market Watch

   Inside the Race for Orphan Drug Status and What It Means for Biotech Investors

9. 

   Jul 31 · 23:44Market Watch

   Behind the Biotech Rally: What Orphan Drug Status Really Means for Stock Prices

10. 

    Jul 31 · 22:14Market Watch

    Inside the Orphan Drug Status Race That Is Reshaping Biotech Investment Strategy

11. 

    Jul 31 · 14:48Market Watch

    The Case For Orphan Drug Status as One of Biotech's Most Powerful Market Catalysts

12. 

    Jul 31 · 11:44Market Watch

    Inside the Orphan Drug Status Race That Is Reshaping Biotech Investment Strategy

13. 

    Jul 30 · 20:44Market Watch

    The Case For Orphan Drug Status as a Biotech Stock Catalyst

14. 

    Jul 29 · 23:44Market Watch

    Inside the Orphan Drug Status Race That's Reshaping Biotech Investment Strategies

15. 

    Jul 29 · 11:48Market Watch

    Orphan Drug Status Is Reshaping Biotech Valuations Faster Than Most Investors Realize

16. 

    Jul 28 · 22:13Market Watch

    The Case For Orphan Drug Status as One of Biotech's Most Powerful Market Catalysts

17. 

    Jul 27 · 19:17Market Watch

    The Case For Orphan Drug Status as One of Pharma's Most Powerful Market Catalysts

18. 

    Jul 26 · 20:44Market Watch

    Orphan Drug Status Is One of the Strongest Market Signals in Biotech — Here's What Investors Miss

19. 

    Jul 25 · 14:32Market Watch

    Orphan Drug Status Is One of the Most Powerful Signals in Biotech Investing

20. 

    Jul 25 · 13:12Market Watch

    Orphan Drug Status Is Reshaping Biotech Investment Signals Faster Than Most Analysts Expected

21. 

    Jul 25 · 11:48Market Watch

    Behind the Rare Disease Gold Rush: What Orphan Drug Status Really Means for Investors

22. 

    Jul 24 · 20:38Market Watch

    Inside the Race for Orphan Drug Status and What It Means for Biotech Investors

23. 

    Jul 24 · 13:15Market Watch

    Behind the Billion-Dollar Designation That's Reshaping Biotech Investment

24. 

    Jul 21 · 10:07Market Watch

    Orphan Drug Status Is Quietly Reshaping the Biotech Investment Landscape